Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
AbstractCombined heart-lung transplantation has been performed in 51 patientssince 1984. A pulmonary preservation fluid preceded by prostacyclininfusion has allowed distant procurement. Early organ function has beengood in all cases. Maintenance immunosuppression is cyclosporine andazathioprine. Steroids are given to treat rejection episodes.Transbronchial biopsy has allowed the accurate, early and safe diagnosis ofrejection. Acute cardiac rejection has not occurred in these patients.Thirty-seven patients are alive between 1 and 54 months followingtransplantation. The actuarial survival at 1 year is 76% and 68% at 2years. Four patients died in the early postoperative period as a result ofprimary Cytomegalovirus (CMV). Other causes of early death were bacterialinfection (4), cerebrovascular event (1), tracheal dehiscence (1) and smallbowel infarction following retransplantation for obliterativebronchiolitis. Three other patients have died as a result of obliterativebronchiolitis. Patients and donors have been carefully selected to ensurethat this scarce resource is utilised most effectively.
European Journal of Cardio-Thoracic Surgery – Oxford University Press
Published: Jul 1, 1989
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.